United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
489.31
+5.21 (1.08%)
At close: Dec 5, 2025, 4:00 PM EST
492.36
+3.05 (0.62%)
After-hours: Dec 5, 2025, 5:31 PM EST
United Therapeutics Stock Forecast
Stock Price Forecast
According to 12 professional analysts, the 12-month price target for United Therapeutics stock ranges from a low of $330 to a high of $600. The average analyst price target of $495.08 forecasts a 1.18% increase in the stock price over the next year.
Price Target: $495.08 (+1.18%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 4 | 4 |
| Buy | 3 | 3 | 5 | 5 | 4 | 4 |
| Hold | 4 | 4 | 4 | 5 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 15 | 16 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $580 → $600 | Strong Buy | Maintains | $580 → $600 | +22.62% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $500 → $525 | Strong Buy | Maintains | $500 → $525 | +7.29% | Oct 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $569 → $587 | Buy | Maintains | $569 → $587 | +19.96% | Oct 30, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $414 → $423 | Hold | Maintains | $414 → $423 | -13.55% | Oct 30, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $328 → $435 | Hold | Maintains | $328 → $435 | -11.10% | Oct 10, 2025 |
Financial Forecast
Revenue This Year
3.27B
from 2.88B
Increased by 13.64%
Revenue Next Year
3.46B
from 3.27B
Increased by 5.78%
EPS This Year
27.61
from 24.64
Increased by 12.05%
EPS Next Year
29.75
from 27.61
Increased by 7.78%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.4B | 3.7B | ||||
| Avg | 3.3B | 3.5B | ||||
| Low | 3.1B | 3.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 18.5% | 13.9% | ||||
| Avg | 13.6% | 5.8% | ||||
| Low | 7.4% | -7.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 29.53 | 34.16 | ||||
| Avg | 27.61 | 29.75 | ||||
| Low | 24.67 | 25.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 19.8% | 23.7% | ||||
| Avg | 12.0% | 7.8% | ||||
| Low | 0.1% | -8.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.